Biotech News
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ir.alxoncology.com2026-04-17 20:12 EST
SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced that the Compensation Committee of